HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-MAR-15 4YZ9 TITLE CRYSTAL STRUCTURE OF HUMAN PHOSPHORYLATED IRE1ALPHA IN COMPLEX WITH A TITLE 2 TYPE III KINASE INHIBITOR (GSK2850163A) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE/ENDORIBONUCLEASE IRE1; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: UNP RESIDUES 562-966; COMPND 5 SYNONYM: ENDOPLASMIC RETICULUM-TO-NUCLEUS SIGNALING 1,INOSITOL- COMPND 6 REQUIRING PROTEIN 1,HIRE1P,IRE1-ALPHA,IRE1A; COMPND 7 EC: 2.7.11.1,3.1.26.-; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ERN1, IRE1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS ACTIVE, INHIBITOR, COMPLEX, IRE1, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.O.CONCHA REVDAT 2 27-SEP-23 4YZ9 1 JRNL REMARK REVDAT 1 11-NOV-15 4YZ9 0 JRNL AUTH N.O.CONCHA,A.SMALLWOOD,W.BONNETTE,R.TOTORITIS,G.ZHANG, JRNL AUTH 2 K.FEDEROWICZ,J.YANG,H.QI,S.CHEN,N.CAMPOBASSO,A.E.CHOUDHRY, JRNL AUTH 3 L.E.SHUSTER,K.A.EVANS,J.RALPH,S.SWEITZER,D.A.HEERDING, JRNL AUTH 4 C.A.BUSER,D.S.SU,M.P.DEYOUNG JRNL TITL LONG-RANGE INHIBITOR-INDUCED CONFORMATIONAL REGULATION OF JRNL TITL 2 HUMAN IRE1 ALPHA ENDORIBONUCLEASE ACTIVITY. JRNL REF MOL.PHARMACOL. V. 88 1011 2015 JRNL REFN ESSN 1521-0111 JRNL PMID 26438213 JRNL DOI 10.1124/MOL.115.100917 REMARK 2 REMARK 2 RESOLUTION. 2.46 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MLHL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.46 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.18 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 59654 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.238 REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.283 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 3016 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.1840 - 6.8736 0.98 2826 153 0.1849 0.2173 REMARK 3 2 6.8736 - 5.4675 1.00 2756 141 0.2179 0.2606 REMARK 3 3 5.4675 - 4.7798 1.00 2719 142 0.1956 0.2316 REMARK 3 4 4.7798 - 4.3443 1.00 2684 135 0.1843 0.2424 REMARK 3 5 4.3443 - 4.0338 1.00 2657 144 0.2041 0.2125 REMARK 3 6 4.0338 - 3.7965 1.00 2667 137 0.2115 0.2924 REMARK 3 7 3.7965 - 3.6067 1.00 2648 160 0.2336 0.3122 REMARK 3 8 3.6067 - 3.4500 0.99 2637 139 0.2548 0.3059 REMARK 3 9 3.4500 - 3.3174 0.99 2636 158 0.2708 0.3614 REMARK 3 10 3.3174 - 3.2030 0.99 2634 112 0.2746 0.2947 REMARK 3 11 3.2030 - 3.1030 0.99 2609 147 0.2820 0.3116 REMARK 3 12 3.1030 - 3.0144 0.99 2620 129 0.2756 0.3238 REMARK 3 13 3.0144 - 2.9351 0.98 2571 141 0.2861 0.3074 REMARK 3 14 2.9351 - 2.8636 0.98 2589 140 0.2853 0.3447 REMARK 3 15 2.8636 - 2.7985 0.98 2567 140 0.3090 0.3217 REMARK 3 16 2.7985 - 2.7390 0.96 2527 135 0.2901 0.3441 REMARK 3 17 2.7390 - 2.6843 0.96 2477 137 0.2888 0.3235 REMARK 3 18 2.6843 - 2.6336 0.95 2552 132 0.2932 0.3711 REMARK 3 19 2.6336 - 2.5866 0.93 2416 125 0.2950 0.3936 REMARK 3 20 2.5866 - 2.5428 0.92 2432 131 0.3031 0.3315 REMARK 3 21 2.5428 - 2.5018 0.89 2319 130 0.3037 0.3417 REMARK 3 22 2.5018 - 2.4633 0.79 2095 108 0.3189 0.3830 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.010 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.87 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 9280 REMARK 3 ANGLE : 0.663 12591 REMARK 3 CHIRALITY : 0.038 1375 REMARK 3 PLANARITY : 0.005 1624 REMARK 3 DIHEDRAL : 14.045 3386 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4YZ9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-APR-15. REMARK 100 THE DEPOSITION ID IS D_1000208329. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-OCT-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX SX-165MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59737 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 29.182 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : 0.07300 REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.7 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : 0.59200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3P23 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS OF PIRE1ALPHA (547 - 977) REMARK 280 WITH GSK2850163 WERE PREPARED BY MIXING PIRE1ALPHA WITH 0.5 MM REMARK 280 GSK2850163 AND INCUBATING OVERNIGHT ON ICE. THE CRYSTALS WERE REMARK 280 GROWN AT 20 C BY VAPOR DIFFUSION IN SITTING DROPS CONTAINING 2 REMARK 280 UL OF PROTEIN (13 MG/ML IN 50 MM HEPES, PH 7.5, 200 MM NACL, 5 REMARK 280 MM DTT, 1 MM EDTA , 0.5 MM GSK2850163, 0.25% DMSO ) AND 2 UL REMARK 280 RESERVOIR SOLUTION CONTAINING PEG 3350 (16%-22%), 100 MM HEPES REMARK 280 PH 7.0, 200 MM CA2+ ACETATE. THE CRYSTALS WERE THICK RODS THAT REMARK 280 APPEARED OVER 2-5 DAYS AND REACHED FULL SIZE (0.05 X 0.025 X 0.3 REMARK 280 MM) IN 2 WEEKS. SEEDING WAS USED TO IMPROVE CRYSTAL QUALITY. THE REMARK 280 PIRE1ALPHA + GSK2850163 CRYSTALS WERE FROZEN IN A SOLUTION OF 20% REMARK 280 ETHYLENE GLYCOL, 22% PEG 3350, 0.2 M CALCIUM ACETATE ADDED IN A REMARK 280 STEPWISE MANNER TO THE PROTEIN DROP BEFORE MOUNTING THE CRYSTAL REMARK 280 ON THE LOOP., VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 122.00200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.88350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 122.00200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.88350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 716 REMARK 465 LYS A 717 REMARK 465 LEU A 718 REMARK 465 ALA A 719 REMARK 465 VAL A 720 REMARK 465 GLY A 721 REMARK 465 ARG A 722 REMARK 465 HIS A 723 REMARK 465 SER A 724 REMARK 465 PHE A 725 REMARK 465 SER A 726 REMARK 465 ARG A 727 REMARK 465 ARG A 728 REMARK 465 SER A 729 REMARK 465 GLY A 730 REMARK 465 VAL A 731 REMARK 465 PRO A 732 REMARK 465 SER A 744 REMARK 465 GLU A 745 REMARK 465 ASP A 746 REMARK 465 CYS A 747 REMARK 465 LYS A 748 REMARK 465 PRO A 965 REMARK 465 PRO A 966 REMARK 465 SER B 562 REMARK 465 LYS B 716 REMARK 465 LYS B 717 REMARK 465 LEU B 718 REMARK 465 ALA B 719 REMARK 465 VAL B 720 REMARK 465 GLY B 721 REMARK 465 ARG B 722 REMARK 465 HIS B 723 REMARK 465 SER B 724 REMARK 465 PHE B 725 REMARK 465 SER B 726 REMARK 465 ARG B 727 REMARK 465 ARG B 728 REMARK 465 SER B 729 REMARK 465 GLY B 730 REMARK 465 VAL B 731 REMARK 465 PRO B 732 REMARK 465 GLY B 733 REMARK 465 THR B 734 REMARK 465 GLU B 745 REMARK 465 ASP B 746 REMARK 465 CYS B 747 REMARK 465 LYS B 748 REMARK 465 GLU B 749 REMARK 465 ARG B 887 REMARK 465 LYS B 888 REMARK 465 GLU B 964 REMARK 465 PRO B 965 REMARK 465 PRO B 966 REMARK 465 LYS C 656 REMARK 465 ASP C 657 REMARK 465 LYS C 716 REMARK 465 LYS C 717 REMARK 465 LEU C 718 REMARK 465 ALA C 719 REMARK 465 VAL C 720 REMARK 465 GLY C 721 REMARK 465 ARG C 722 REMARK 465 HIS C 723 REMARK 465 SER C 724 REMARK 465 PHE C 725 REMARK 465 SER C 726 REMARK 465 ARG C 727 REMARK 465 ARG C 728 REMARK 465 SER C 729 REMARK 465 GLY C 730 REMARK 465 VAL C 731 REMARK 465 PRO C 732 REMARK 465 GLY C 733 REMARK 465 GLU C 745 REMARK 465 ASP C 746 REMARK 465 CYS C 747 REMARK 465 LYS C 748 REMARK 465 GLU C 749 REMARK 465 PRO C 965 REMARK 465 PRO C 966 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 562 OG REMARK 470 LYS A 568 CD CE NZ REMARK 470 ARG A 635 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 642 CD1 REMARK 470 LYS A 656 CG CD CE NZ REMARK 470 HIS A 660 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 704 CD CE NZ REMARK 470 GLU A 735 CG CD OE1 OE2 REMARK 470 ASN A 750 CG OD1 ND2 REMARK 470 LYS A 777 CG CD CE NZ REMARK 470 LYS A 851 CG CD CE NZ REMARK 470 LYS A 860 CG CD CE NZ REMARK 470 ARG A 864 CD NE CZ NH1 NH2 REMARK 470 ARG A 867 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 887 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 888 CG CD CE NZ REMARK 470 PHE A 889 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 890 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 912 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 964 CG CD OE1 OE2 REMARK 470 LYS B 574 CG CD CE NZ REMARK 470 ASP B 575 CG OD1 OD2 REMARK 470 GLU B 582 CG CD OE1 OE2 REMARK 470 PHE B 608 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 611 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 620 CG OD1 OD2 REMARK 470 LYS B 656 CG CD CE NZ REMARK 470 ASP B 657 CG OD1 OD2 REMARK 470 HIS B 660 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 704 CD CE NZ REMARK 470 GLU B 735 CG CD OE1 OE2 REMARK 470 ILE B 849 CG1 CG2 CD1 REMARK 470 LYS B 851 CG CD CE NZ REMARK 470 LYS B 860 CG CD CE NZ REMARK 470 ARG B 864 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 867 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 885 CG OD1 OD2 REMARK 470 LEU B 886 CG CD1 CD2 REMARK 470 ARG B 890 CG CD NE CZ NH1 NH2 REMARK 470 THR B 891 OG1 CG2 REMARK 470 LYS B 907 CG CD CE NZ REMARK 470 LYS B 908 CG CD CE NZ REMARK 470 ARG B 912 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 913 CG CD OE1 OE2 REMARK 470 ARG B 919 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 920 CG CD OE1 OE2 REMARK 470 HIS B 963 CG ND1 CD2 CE1 NE2 REMARK 470 SER C 562 OG REMARK 470 GLU C 604 CG CD OE1 OE2 REMARK 470 PHE C 608 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ILE C 642 CD1 REMARK 470 LEU C 661 CG CD1 CD2 REMARK 470 LYS C 704 CG CD CE NZ REMARK 470 GLU C 735 CG CD OE1 OE2 REMARK 470 LYS C 777 CG CD CE NZ REMARK 470 LYS C 851 CG CD CE NZ REMARK 470 ASP C 855 CG OD1 OD2 REMARK 470 LYS C 860 CG CD CE NZ REMARK 470 ARG C 864 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 867 CG CD NE CZ NH1 NH2 REMARK 470 VAL C 870 CG1 CG2 REMARK 470 ASN C 877 CG OD1 ND2 REMARK 470 ARG C 946 CG CD NE CZ NH1 NH2 REMARK 470 GLN C 958 CG CD OE1 NE2 REMARK 470 GLU C 964 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU C 632 H TYR C 639 1.60 REMARK 500 O LEU B 862 HE2 HIS B 943 1.60 REMARK 500 O GLU B 850 NH2 ARG B 898 2.12 REMARK 500 OE2 GLU A 621 O HOH A 1101 2.17 REMARK 500 OD2 ASP A 885 NZ LYS A 907 2.19 REMARK 500 O LEU C 914 NH1 ARG C 919 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 581 84.42 55.08 REMARK 500 GLU A 582 40.30 74.72 REMARK 500 LYS A 656 -2.65 76.38 REMARK 500 ARG A 687 -20.46 75.18 REMARK 500 LEU A 854 -18.43 75.13 REMARK 500 MET A 872 -20.15 75.80 REMARK 500 THR A 891 -129.55 63.12 REMARK 500 LEU A 922 -76.25 -95.05 REMARK 500 VAL B 566 -76.71 -103.70 REMARK 500 PHE B 629 -64.89 -99.79 REMARK 500 LYS B 656 -4.72 71.15 REMARK 500 ARG B 687 -19.19 76.22 REMARK 500 LEU B 743 -63.84 -94.90 REMARK 500 SER B 853 -12.36 83.80 REMARK 500 LEU B 854 -17.82 74.01 REMARK 500 ARG B 867 -18.17 75.60 REMARK 500 MET B 872 -120.90 62.19 REMARK 500 LEU B 925 150.26 68.41 REMARK 500 LYS C 568 -8.52 85.09 REMARK 500 ASN C 593 -3.83 69.25 REMARK 500 PHE C 629 -63.37 -100.01 REMARK 500 ARG C 687 -15.77 66.00 REMARK 500 LEU C 779 -70.14 -52.71 REMARK 500 MET C 872 -20.64 74.54 REMARK 500 LEU C 922 -167.07 -72.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 580 ALA A 581 132.42 REMARK 500 LEU B 922 GLY B 923 -147.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4K7 A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4K7 B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4K7 C 1001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4YZC RELATED DB: PDB REMARK 900 RELATED ID: 4YZD RELATED DB: PDB DBREF 4YZ9 A 562 966 UNP O75460 ERN1_HUMAN 562 966 DBREF 4YZ9 B 562 966 UNP O75460 ERN1_HUMAN 562 966 DBREF 4YZ9 C 562 966 UNP O75460 ERN1_HUMAN 562 966 SEQRES 1 A 405 SER VAL VAL ILE VAL GLY LYS ILE SER PHE CYS PRO LYS SEQRES 2 A 405 ASP VAL LEU GLY HIS GLY ALA GLU GLY THR ILE VAL TYR SEQRES 3 A 405 ARG GLY MET PHE ASP ASN ARG ASP VAL ALA VAL LYS ARG SEQRES 4 A 405 ILE LEU PRO GLU CYS PHE SER PHE ALA ASP ARG GLU VAL SEQRES 5 A 405 GLN LEU LEU ARG GLU SER ASP GLU HIS PRO ASN VAL ILE SEQRES 6 A 405 ARG TYR PHE CYS THR GLU LYS ASP ARG GLN PHE GLN TYR SEQRES 7 A 405 ILE ALA ILE GLU LEU CYS ALA ALA THR LEU GLN GLU TYR SEQRES 8 A 405 VAL GLU GLN LYS ASP PHE ALA HIS LEU GLY LEU GLU PRO SEQRES 9 A 405 ILE THR LEU LEU GLN GLN THR THR SER GLY LEU ALA HIS SEQRES 10 A 405 LEU HIS SER LEU ASN ILE VAL HIS ARG ASP LEU LYS PRO SEQRES 11 A 405 HIS ASN ILE LEU ILE SER MET PRO ASN ALA HIS GLY LYS SEQRES 12 A 405 ILE LYS ALA MET ILE SER ASP PHE GLY LEU CYS LYS LYS SEQRES 13 A 405 LEU ALA VAL GLY ARG HIS SER PHE SER ARG ARG SER GLY SEQRES 14 A 405 VAL PRO GLY THR GLU GLY TRP ILE ALA PRO GLU MET LEU SEQRES 15 A 405 SER GLU ASP CYS LYS GLU ASN PRO THR TYR THR VAL ASP SEQRES 16 A 405 ILE PHE SER ALA GLY CYS VAL PHE TYR TYR VAL ILE SER SEQRES 17 A 405 GLU GLY SER HIS PRO PHE GLY LYS SER LEU GLN ARG GLN SEQRES 18 A 405 ALA ASN ILE LEU LEU GLY ALA CYS SER LEU ASP CYS LEU SEQRES 19 A 405 HIS PRO GLU LYS HIS GLU ASP VAL ILE ALA ARG GLU LEU SEQRES 20 A 405 ILE GLU LYS MET ILE ALA MET ASP PRO GLN LYS ARG PRO SEQRES 21 A 405 SER ALA LYS HIS VAL LEU LYS HIS PRO PHE PHE TRP SER SEQRES 22 A 405 LEU GLU LYS GLN LEU GLN PHE PHE GLN ASP VAL SER ASP SEQRES 23 A 405 ARG ILE GLU LYS GLU SER LEU ASP GLY PRO ILE VAL LYS SEQRES 24 A 405 GLN LEU GLU ARG GLY GLY ARG ALA VAL VAL LYS MET ASP SEQRES 25 A 405 TRP ARG GLU ASN ILE THR VAL PRO LEU GLN THR ASP LEU SEQRES 26 A 405 ARG LYS PHE ARG THR TYR LYS GLY GLY SER VAL ARG ASP SEQRES 27 A 405 LEU LEU ARG ALA MET ARG ASN LYS LYS HIS HIS TYR ARG SEQRES 28 A 405 GLU LEU PRO ALA GLU VAL ARG GLU THR LEU GLY SER LEU SEQRES 29 A 405 PRO ASP ASP PHE VAL CYS TYR PHE THR SER ARG PHE PRO SEQRES 30 A 405 HIS LEU LEU ALA HIS THR TYR ARG ALA MET GLU LEU CYS SEQRES 31 A 405 SER HIS GLU ARG LEU PHE GLN PRO TYR TYR PHE HIS GLU SEQRES 32 A 405 PRO PRO SEQRES 1 B 405 SER VAL VAL ILE VAL GLY LYS ILE SER PHE CYS PRO LYS SEQRES 2 B 405 ASP VAL LEU GLY HIS GLY ALA GLU GLY THR ILE VAL TYR SEQRES 3 B 405 ARG GLY MET PHE ASP ASN ARG ASP VAL ALA VAL LYS ARG SEQRES 4 B 405 ILE LEU PRO GLU CYS PHE SER PHE ALA ASP ARG GLU VAL SEQRES 5 B 405 GLN LEU LEU ARG GLU SER ASP GLU HIS PRO ASN VAL ILE SEQRES 6 B 405 ARG TYR PHE CYS THR GLU LYS ASP ARG GLN PHE GLN TYR SEQRES 7 B 405 ILE ALA ILE GLU LEU CYS ALA ALA THR LEU GLN GLU TYR SEQRES 8 B 405 VAL GLU GLN LYS ASP PHE ALA HIS LEU GLY LEU GLU PRO SEQRES 9 B 405 ILE THR LEU LEU GLN GLN THR THR SER GLY LEU ALA HIS SEQRES 10 B 405 LEU HIS SER LEU ASN ILE VAL HIS ARG ASP LEU LYS PRO SEQRES 11 B 405 HIS ASN ILE LEU ILE SER MET PRO ASN ALA HIS GLY LYS SEQRES 12 B 405 ILE LYS ALA MET ILE SER ASP PHE GLY LEU CYS LYS LYS SEQRES 13 B 405 LEU ALA VAL GLY ARG HIS SER PHE SER ARG ARG SER GLY SEQRES 14 B 405 VAL PRO GLY THR GLU GLY TRP ILE ALA PRO GLU MET LEU SEQRES 15 B 405 SER GLU ASP CYS LYS GLU ASN PRO THR TYR THR VAL ASP SEQRES 16 B 405 ILE PHE SER ALA GLY CYS VAL PHE TYR TYR VAL ILE SER SEQRES 17 B 405 GLU GLY SER HIS PRO PHE GLY LYS SER LEU GLN ARG GLN SEQRES 18 B 405 ALA ASN ILE LEU LEU GLY ALA CYS SER LEU ASP CYS LEU SEQRES 19 B 405 HIS PRO GLU LYS HIS GLU ASP VAL ILE ALA ARG GLU LEU SEQRES 20 B 405 ILE GLU LYS MET ILE ALA MET ASP PRO GLN LYS ARG PRO SEQRES 21 B 405 SER ALA LYS HIS VAL LEU LYS HIS PRO PHE PHE TRP SER SEQRES 22 B 405 LEU GLU LYS GLN LEU GLN PHE PHE GLN ASP VAL SER ASP SEQRES 23 B 405 ARG ILE GLU LYS GLU SER LEU ASP GLY PRO ILE VAL LYS SEQRES 24 B 405 GLN LEU GLU ARG GLY GLY ARG ALA VAL VAL LYS MET ASP SEQRES 25 B 405 TRP ARG GLU ASN ILE THR VAL PRO LEU GLN THR ASP LEU SEQRES 26 B 405 ARG LYS PHE ARG THR TYR LYS GLY GLY SER VAL ARG ASP SEQRES 27 B 405 LEU LEU ARG ALA MET ARG ASN LYS LYS HIS HIS TYR ARG SEQRES 28 B 405 GLU LEU PRO ALA GLU VAL ARG GLU THR LEU GLY SER LEU SEQRES 29 B 405 PRO ASP ASP PHE VAL CYS TYR PHE THR SER ARG PHE PRO SEQRES 30 B 405 HIS LEU LEU ALA HIS THR TYR ARG ALA MET GLU LEU CYS SEQRES 31 B 405 SER HIS GLU ARG LEU PHE GLN PRO TYR TYR PHE HIS GLU SEQRES 32 B 405 PRO PRO SEQRES 1 C 405 SER VAL VAL ILE VAL GLY LYS ILE SER PHE CYS PRO LYS SEQRES 2 C 405 ASP VAL LEU GLY HIS GLY ALA GLU GLY THR ILE VAL TYR SEQRES 3 C 405 ARG GLY MET PHE ASP ASN ARG ASP VAL ALA VAL LYS ARG SEQRES 4 C 405 ILE LEU PRO GLU CYS PHE SER PHE ALA ASP ARG GLU VAL SEQRES 5 C 405 GLN LEU LEU ARG GLU SER ASP GLU HIS PRO ASN VAL ILE SEQRES 6 C 405 ARG TYR PHE CYS THR GLU LYS ASP ARG GLN PHE GLN TYR SEQRES 7 C 405 ILE ALA ILE GLU LEU CYS ALA ALA THR LEU GLN GLU TYR SEQRES 8 C 405 VAL GLU GLN LYS ASP PHE ALA HIS LEU GLY LEU GLU PRO SEQRES 9 C 405 ILE THR LEU LEU GLN GLN THR THR SER GLY LEU ALA HIS SEQRES 10 C 405 LEU HIS SER LEU ASN ILE VAL HIS ARG ASP LEU LYS PRO SEQRES 11 C 405 HIS ASN ILE LEU ILE SER MET PRO ASN ALA HIS GLY LYS SEQRES 12 C 405 ILE LYS ALA MET ILE SER ASP PHE GLY LEU CYS LYS LYS SEQRES 13 C 405 LEU ALA VAL GLY ARG HIS SER PHE SER ARG ARG SER GLY SEQRES 14 C 405 VAL PRO GLY THR GLU GLY TRP ILE ALA PRO GLU MET LEU SEQRES 15 C 405 SER GLU ASP CYS LYS GLU ASN PRO THR TYR THR VAL ASP SEQRES 16 C 405 ILE PHE SER ALA GLY CYS VAL PHE TYR TYR VAL ILE SER SEQRES 17 C 405 GLU GLY SER HIS PRO PHE GLY LYS SER LEU GLN ARG GLN SEQRES 18 C 405 ALA ASN ILE LEU LEU GLY ALA CYS SER LEU ASP CYS LEU SEQRES 19 C 405 HIS PRO GLU LYS HIS GLU ASP VAL ILE ALA ARG GLU LEU SEQRES 20 C 405 ILE GLU LYS MET ILE ALA MET ASP PRO GLN LYS ARG PRO SEQRES 21 C 405 SER ALA LYS HIS VAL LEU LYS HIS PRO PHE PHE TRP SER SEQRES 22 C 405 LEU GLU LYS GLN LEU GLN PHE PHE GLN ASP VAL SER ASP SEQRES 23 C 405 ARG ILE GLU LYS GLU SER LEU ASP GLY PRO ILE VAL LYS SEQRES 24 C 405 GLN LEU GLU ARG GLY GLY ARG ALA VAL VAL LYS MET ASP SEQRES 25 C 405 TRP ARG GLU ASN ILE THR VAL PRO LEU GLN THR ASP LEU SEQRES 26 C 405 ARG LYS PHE ARG THR TYR LYS GLY GLY SER VAL ARG ASP SEQRES 27 C 405 LEU LEU ARG ALA MET ARG ASN LYS LYS HIS HIS TYR ARG SEQRES 28 C 405 GLU LEU PRO ALA GLU VAL ARG GLU THR LEU GLY SER LEU SEQRES 29 C 405 PRO ASP ASP PHE VAL CYS TYR PHE THR SER ARG PHE PRO SEQRES 30 C 405 HIS LEU LEU ALA HIS THR TYR ARG ALA MET GLU LEU CYS SEQRES 31 C 405 SER HIS GLU ARG LEU PHE GLN PRO TYR TYR PHE HIS GLU SEQRES 32 C 405 PRO PRO HET 4K7 A1001 59 HET 4K7 B1001 59 HET 4K7 C1001 59 HETNAM 4K7 (5R)-2-(3,4-DICHLOROBENZYL)-N-(4-METHYLBENZYL)-2,7- HETNAM 2 4K7 DIAZASPIRO[4.5]DECANE-7-CARBOXAMIDE FORMUL 4 4K7 3(C24 H29 CL2 N3 O) FORMUL 7 HOH *80(H2 O) HELIX 1 AA1 LEU A 602 GLU A 604 5 3 HELIX 2 AA2 CYS A 605 GLU A 618 1 14 HELIX 3 AA3 LEU A 649 LYS A 656 1 8 HELIX 4 AA4 ASP A 657 GLY A 662 5 6 HELIX 5 AA5 GLU A 664 LEU A 682 1 19 HELIX 6 AA6 TYR A 753 SER A 769 1 17 HELIX 7 AA7 LYS A 777 LEU A 779 5 3 HELIX 8 AA8 GLN A 780 GLY A 788 1 9 HELIX 9 AA9 LYS A 799 ILE A 813 1 15 HELIX 10 AB1 ASP A 816 ARG A 820 5 5 HELIX 11 AB2 SER A 822 LYS A 828 1 7 HELIX 12 AB3 HIS A 829 TRP A 833 5 5 HELIX 13 AB4 SER A 834 GLU A 850 1 17 HELIX 14 AB5 GLY A 856 GLY A 866 1 11 HELIX 15 AB6 GLY A 866 LYS A 871 1 6 HELIX 16 AB7 THR A 879 LYS A 888 1 10 HELIX 17 AB8 SER A 896 HIS A 910 1 15 HELIX 18 AB9 TYR A 911 LEU A 914 5 4 HELIX 19 AC1 PRO A 915 GLY A 923 1 9 HELIX 20 AC2 PRO A 926 PHE A 937 1 12 HELIX 21 AC3 HIS A 939 MET A 948 1 10 HELIX 22 AC4 GLU A 949 SER A 952 5 4 HELIX 23 AC5 GLU A 954 GLN A 958 5 5 HELIX 24 AC6 LEU B 602 GLU B 604 5 3 HELIX 25 AC7 CYS B 605 SER B 619 1 15 HELIX 26 AC8 LEU B 649 LYS B 656 1 8 HELIX 27 AC9 ASP B 657 HIS B 660 5 4 HELIX 28 AD1 GLU B 664 LEU B 682 1 19 HELIX 29 AD2 ALA B 739 LEU B 743 5 5 HELIX 30 AD3 TYR B 753 SER B 769 1 17 HELIX 31 AD4 GLN B 780 LEU B 787 1 8 HELIX 32 AD5 LYS B 799 ILE B 813 1 15 HELIX 33 AD6 ASP B 816 ARG B 820 5 5 HELIX 34 AD7 SER B 822 HIS B 829 1 8 HELIX 35 AD8 PRO B 830 TRP B 833 5 4 HELIX 36 AD9 SER B 834 ILE B 849 1 16 HELIX 37 AE1 GLY B 856 GLY B 865 1 10 HELIX 38 AE2 THR B 879 LEU B 886 1 8 HELIX 39 AE3 SER B 896 HIS B 910 1 15 HELIX 40 AE4 TYR B 911 LEU B 914 5 4 HELIX 41 AE5 PRO B 915 GLY B 923 1 9 HELIX 42 AE6 PRO B 926 PHE B 937 1 12 HELIX 43 AE7 HIS B 939 MET B 948 1 10 HELIX 44 AE8 GLU B 949 SER B 952 5 4 HELIX 45 AE9 PHE B 957 TYR B 961 5 5 HELIX 46 AF1 ALA C 581 GLY C 583 5 3 HELIX 47 AF2 LEU C 602 GLU C 604 5 3 HELIX 48 AF3 CYS C 605 SER C 619 1 15 HELIX 49 AF4 LEU C 649 GLN C 655 1 7 HELIX 50 AF5 GLU C 664 LEU C 682 1 19 HELIX 51 AF6 LYS C 690 HIS C 692 5 3 HELIX 52 AF7 ALA C 739 SER C 744 1 6 HELIX 53 AF8 TYR C 753 SER C 769 1 17 HELIX 54 AF9 GLN C 780 GLY C 788 1 9 HELIX 55 AG1 LYS C 799 ILE C 813 1 15 HELIX 56 AG2 ASP C 816 ARG C 820 5 5 HELIX 57 AG3 SER C 822 LYS C 828 1 7 HELIX 58 AG4 HIS C 829 TRP C 833 5 5 HELIX 59 AG5 SER C 834 LYS C 851 1 18 HELIX 60 AG6 GLY C 856 ARG C 864 1 9 HELIX 61 AG7 GLY C 865 VAL C 870 1 6 HELIX 62 AG8 THR C 879 LYS C 888 1 10 HELIX 63 AG9 SER C 896 HIS C 910 1 15 HELIX 64 AH1 TYR C 911 LEU C 914 5 4 HELIX 65 AH2 PRO C 915 LEU C 922 1 8 HELIX 66 AH3 PRO C 926 PHE C 937 1 12 HELIX 67 AH4 HIS C 939 MET C 948 1 10 HELIX 68 AH5 GLU C 949 SER C 952 5 4 HELIX 69 AH6 GLU C 954 TYR C 961 5 8 SHEET 1 AA1 6 VAL A 564 ILE A 565 0 SHEET 2 AA1 6 ILE A 569 GLY A 580 -1 O PHE A 571 N VAL A 564 SHEET 3 AA1 6 THR A 584 PHE A 591 -1 O VAL A 586 N LEU A 577 SHEET 4 AA1 6 ARG A 594 ILE A 601 -1 O VAL A 598 N TYR A 587 SHEET 5 AA1 6 GLN A 638 ILE A 642 -1 O ILE A 642 N ALA A 597 SHEET 6 AA1 6 TYR A 628 LYS A 633 -1 N GLU A 632 O TYR A 639 SHEET 1 AA2 3 CYS A 645 THR A 648 0 SHEET 2 AA2 3 ILE A 694 SER A 697 -1 O ILE A 696 N ALA A 647 SHEET 3 AA2 3 ALA A 707 ILE A 709 -1 O MET A 708 N LEU A 695 SHEET 1 AA3 6 VAL B 564 ILE B 565 0 SHEET 2 AA3 6 ILE B 569 GLY B 580 -1 O PHE B 571 N VAL B 564 SHEET 3 AA3 6 THR B 584 PHE B 591 -1 O MET B 590 N SER B 570 SHEET 4 AA3 6 ARG B 594 ILE B 601 -1 O ARG B 600 N ILE B 585 SHEET 5 AA3 6 GLN B 638 GLU B 643 -1 O ILE B 640 N LYS B 599 SHEET 6 AA3 6 TYR B 628 LYS B 633 -1 N GLU B 632 O TYR B 639 SHEET 1 AA4 3 VAL B 564 ILE B 565 0 SHEET 2 AA4 3 ILE B 569 GLY B 580 -1 O PHE B 571 N VAL B 564 SHEET 3 AA4 3 GLY B 713 LEU B 714 -1 O GLY B 713 N HIS B 579 SHEET 1 AA5 3 CYS B 645 THR B 648 0 SHEET 2 AA5 3 ILE B 694 SER B 697 -1 O ILE B 696 N ALA B 647 SHEET 3 AA5 3 ALA B 707 ILE B 709 -1 O MET B 708 N LEU B 695 SHEET 1 AA6 6 VAL C 564 VAL C 566 0 SHEET 2 AA6 6 ILE C 569 GLY C 580 -1 O ILE C 569 N VAL C 566 SHEET 3 AA6 6 THR C 584 PHE C 591 -1 O MET C 590 N SER C 570 SHEET 4 AA6 6 ARG C 594 ILE C 601 -1 O ARG C 600 N ILE C 585 SHEET 5 AA6 6 GLN C 638 GLU C 643 -1 O ILE C 640 N LYS C 599 SHEET 6 AA6 6 TYR C 628 LYS C 633 -1 N GLU C 632 O TYR C 639 SHEET 1 AA7 3 ALA C 647 THR C 648 0 SHEET 2 AA7 3 ILE C 694 ILE C 696 -1 O ILE C 696 N ALA C 647 SHEET 3 AA7 3 ALA C 707 ILE C 709 -1 O MET C 708 N LEU C 695 CISPEP 1 LEU A 925 PRO A 926 0 -14.14 CISPEP 2 LEU B 925 PRO B 926 0 -21.80 CISPEP 3 LEU C 925 PRO C 926 0 -8.62 SITE 1 AC1 13 ALA A 581 THR A 584 LYS A 599 CYS A 605 SITE 2 AC1 13 ALA A 609 GLU A 612 VAL A 613 ILE A 626 SITE 3 AC1 13 LEU A 679 ILE A 684 VAL A 685 HIS A 686 SITE 4 AC1 13 ASP A 711 SITE 1 AC2 9 ALA B 581 THR B 584 LYS B 599 ALA B 609 SITE 2 AC2 9 GLU B 612 ILE B 626 HIS B 686 ARG B 687 SITE 3 AC2 9 ASP B 711 SITE 1 AC3 11 ALA C 581 THR C 584 LYS C 599 ALA C 609 SITE 2 AC3 11 GLU C 612 VAL C 613 ILE C 626 ILE C 684 SITE 3 AC3 11 VAL C 685 HIS C 686 ASP C 711 CRYST1 244.004 77.767 88.313 90.00 90.00 90.00 P 21 21 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004098 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012859 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011323 0.00000